Edmond DE Rothschild Holding S.A. purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 4,503,300 shares of the medical instruments supplier's stock, valued at approximately $47,780,000. Edmond DE Rothschild Holding S.A. owned approximately 2.26% of DENTSPLY SIRONA as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently modified their holdings of XRAY. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 3.2% in the fourth quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier's stock worth $167,342,000 after purchasing an additional 458,744 shares during the last quarter. UBS Group AG lifted its holdings in shares of DENTSPLY SIRONA by 63.7% during the 4th quarter. UBS Group AG now owns 1,701,980 shares of the medical instruments supplier's stock valued at $19,454,000 after purchasing an additional 662,000 shares during the last quarter. Fiduciary Alliance LLC purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at $4,607,000. Cibc World Market Inc. boosted its position in shares of DENTSPLY SIRONA by 120.7% in the 4th quarter. Cibc World Market Inc. now owns 1,184,303 shares of the medical instruments supplier's stock worth $13,537,000 after purchasing an additional 647,763 shares in the last quarter. Finally, Skylands Capital LLC purchased a new position in DENTSPLY SIRONA during the 4th quarter worth $1,079,000. Hedge funds and other institutional investors own 95.70% of the company's stock.
Insider Activity at DENTSPLY SIRONA
In other DENTSPLY SIRONA news, Director Brian T. Gladden purchased 9,985 shares of the stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $10.02 per share, with a total value of $100,049.70. Following the completion of the acquisition, the director owned 61,849 shares in the company, valued at $619,726.98. This trade represents a 19.25% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Michael J. Barber purchased 15,175 shares of the business's stock in a transaction on Thursday, June 11th. The shares were bought at an average cost of $9.88 per share, for a total transaction of $149,929.00. Following the completion of the transaction, the director directly owned 55,943 shares in the company, valued at $552,716.84. This trade represents a 37.22% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired 35,160 shares of company stock worth $351,179 over the last three months. Company insiders own 0.46% of the company's stock.
Analyst Ratings Changes
Several brokerages recently issued reports on XRAY. UBS Group reduced their target price on DENTSPLY SIRONA from $18.00 to $17.00 and set a "buy" rating on the stock in a research report on Thursday, May 7th. Mizuho dropped their price target on DENTSPLY SIRONA from $16.00 to $14.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 6th. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, August 10th. BMO Capital Markets reaffirmed a "market perform" rating and issued a $13.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, August 7th. Finally, Piper Sandler lifted their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus price target of $13.38.
View Our Latest Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Price Performance
Shares of NASDAQ XRAY opened at $11.03 on Thursday. DENTSPLY SIRONA Inc. has a 52 week low of $9.40 and a 52 week high of $14.86. The business's 50 day moving average price is $11.99 and its 200 day moving average price is $11.82. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The firm has a market cap of $2.20 billion, a P/E ratio of -4.01, a P/E/G ratio of 1.40 and a beta of 0.85.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.35 by $0.17. The business had revenue of $898.00 million during the quarter, compared to analysts' expectations of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current year.
DENTSPLY SIRONA Profile
(
Free Report)
Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
Featured Articles
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
